After Gilead Sciences, More Biotech M&A?

After Gilead Sciences, More Biotech M&A?
When Gilead Sciences GILD announced that it would pay 11 9 billion to acquire Kite Pharma KITE it was good news for Kite obviously and Gilead too Their shared have gained 13 and 29 respectively since the announcement But it s also been good for biotech stocks generally
After Gilead Sciences, More Biotech M&A?
XIV Trading Strategy : Nasdaq

You must be logged in to post a comment.